ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,898, issued on July 22, was assigned to The Medical College of Wisconsin Inc. (Milwaukee).
"Calcium channel 3.2 inhibitory peptides and uses thereof" was invented by Quinn H. Hogan (Milwaukee) and Hongwei Yu (Milwaukee).
According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the disclosure relate to constructs comprising one or more Cav3.2 inhibitory polypeptide that blocks Cav3.2 T-type calcium channel activity and nociceptive dorsal root ganglion (DRG) neuron excitation. Also provided herein are methods for treating pain in a subject in need thereof. In particular, provided herein are methods comprising administering Cav3.2 inhibitory peptide con...